Labeaga L - Search Results

1

Bilastine vs. hydroxyzine: occupation of brain histamine H1 -receptors evaluated by positron emission tomography in healthy volunteers.

Farré M, Pérez-Mañá C, Papaseit E, Menoyo E, Pérez M, Martin S, Bullich S, Rojas S, Herance JR, Trampal C, Labeaga L, Valiente R. Farré M, et al. Among authors: labeaga l. Br J Clin Pharmacol. 2014 Nov;78(5):970-80. doi: 10.1111/bcp.12421. Br J Clin Pharmacol. 2014. PMID: 24833043 Free PMC article. Clinical Trial.

2

Bilastine: a new antihistamine with an optimal benefit-to-risk ratio for safety during driving.

Jáuregui I, Ramaekers JG, Yanai K, Farré M, Redondo E, Valiente R, Labeaga L. Jáuregui I, et al. Among authors: labeaga l. Expert Opin Drug Saf. 2016 Jan;15(1):89-98. doi: 10.1517/14740338.2016.1112786. Epub 2015 Nov 16. Expert Opin Drug Saf. 2016. PMID: 26571227 Review.

3

Comparative efficacy of bilastine, desloratadine and rupatadine in the suppression of wheal and flare response induced by intradermal histamine in healthy volunteers.

Antonijoan R, Coimbra J, García-Gea C, Puntes M, Gich I, Campo C, Valiente R, Labeaga L. Antonijoan R, et al. Among authors: labeaga l. Curr Med Res Opin. 2017 Jan;33(1):129-136. doi: 10.1080/03007995.2016.1240665. Epub 2016 Oct 21. Curr Med Res Opin. 2017. PMID: 27659218 Clinical Trial.

4

Bioequivalence Evaluation of Three Pediatric Oral Formulations of Bilastine in Healthy Subjects: Results from a Randomized, Open Label, Crossover Study.

Sádaba B, Azanza JR, García-Bea A, Labeaga L, Campo C, Valiente R. Sádaba B, et al. Among authors: labeaga l. Eur J Drug Metab Pharmacokinet. 2020 Apr;45(2):265-272. doi: 10.1007/s13318-019-00596-2. Eur J Drug Metab Pharmacokinet. 2020. PMID: 31820304 Clinical Trial.

5

Model-informed pediatric development applied to bilastine: Analysis of the clinical PK data and confirmation of the dose selected for the target population.

Vozmediano V, Lukas JC, Encinas E, Schmidt S, Sologuren A, Valiente R, Labeaga L, Campo C, Rodriguez M. Vozmediano V, et al. Among authors: labeaga l. Eur J Pharm Sci. 2019 Feb 1;128:180-192. doi: 10.1016/j.ejps.2018.11.016. Epub 2018 Nov 22. Eur J Pharm Sci. 2019. PMID: 30468868

6

Cognitive Performance Effects of Bilastine 20 mg During 6 Hours at 8000 ft Cabin Altitude.

Valk PJ, Simons R, Jetten AM, Valiente R, Labeaga L. Valk PJ, et al. Among authors: labeaga l. Aerosp Med Hum Perform. 2016 Jul;87(7):622-7. doi: 10.3357/AMHP.4522.2016. Aerosp Med Hum Perform. 2016. PMID: 27503042 Clinical Trial.

Our findings might also have implications for the treatment of allergic disorders of personnel involved in other safety-sensitive jobs. Valk PJL, Simons R, Jetten AM, Valiente R, Labeaga L. Cognitive performance effects of bilastine 20 mg during 6 hours at 8000 ft c …

Our findings might also have implications for the treatment of allergic disorders of personnel involved in other safety-sensitive jobs. Valk …

7

Bilastine in allergic rhinoconjunctivitis and urticaria: a practical approach to treatment decisions based on queries received by the medical information department.

Leceta A, Sologuren A, Valiente R, Campo C, Labeaga L. Leceta A, et al. Among authors: labeaga l. Drugs Context. 2017 Feb 3;6:212500. doi: 10.7573/dic.212500. eCollection 2017. Drugs Context. 2017. PMID: 28210286 Free PMC article. Review.

8

The long duration of action of the second generation antihistamine bilastine coincides with its long residence time at the histamine H₁ receptor.

Bosma R, van den Bor J, Vischer HF, Labeaga L, Leurs R. Bosma R, et al. Among authors: labeaga l. Eur J Pharmacol. 2018 Nov 5;838:107-111. doi: 10.1016/j.ejphar.2018.09.011. Epub 2018 Sep 7. Eur J Pharmacol. 2018. PMID: 30201377 Free article.

9

Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist: receptor selectivity and in vitro antihistaminic activity.

Corcóstegui R, Labeaga L, Innerárity A, Berisa A, Orjales A. Corcóstegui R, et al. Among authors: labeaga l. Drugs R D. 2005;6(6):371-84. doi: 10.2165/00126839-200506060-00005. Drugs R D. 2005. PMID: 16274260

10

Bilastine: a new H₁ -antihistamine with an optimal profile for updosing in urticaria.

Church MK, Labeaga L. Church MK, et al. Among authors: labeaga l. J Eur Acad Dermatol Venereol. 2017 Sep;31(9):1447-1452. doi: 10.1111/jdv.14305. Epub 2017 Jun 1. J Eur Acad Dermatol Venereol. 2017. PMID: 28467671 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page